Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,231,628
  • Shares Outstanding, K 38,914
  • Annual Sales, $ 0 K
  • Annual Income, $ -130,400 K
  • 60-Month Beta 2.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 83.42
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 199.43% ( -1.10%)
  • Historical Volatility 151.14%
  • IV Percentile 96%
  • IV Rank 85.33%
  • IV High 223.88% on 05/09/22
  • IV Low 57.24% on 06/25/21
  • Put/Call Vol Ratio 0.50
  • Today's Volume 5,627
  • Volume Avg (30-Day) 6,485
  • Put/Call OI Ratio 0.75
  • Today's Open Interest 121,543
  • Open Int (30-Day) 93,431

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -1.04
  • Number of Estimates 7
  • High Estimate -0.97
  • Low Estimate -1.16
  • Prior Year -0.86
  • Growth Rate Est. (year over year) -20.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.13 +31.16%
on 05/12/22
44.53 -28.92%
on 04/21/22
-11.39 (-26.46%)
since 04/20/22
3-Month
24.13 +31.16%
on 05/12/22
47.40 -33.23%
on 04/05/22
+2.08 (+7.03%)
since 02/18/22
52-Week
19.38 +63.31%
on 08/19/21
74.10 -57.29%
on 06/28/21
-23.90 (-43.02%)
since 05/20/21

Most Recent Stories

More News
AXSM Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Axsome Therapeutics, Inc. (AXSM)

The Class : Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Axsome Therapeutics,...

AXSM : 31.65 (+0.44%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Axsome Therapeutics, Inc. (AXSM) Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired...

AXSM : 31.65 (+0.44%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Axsome Therapeutics, Inc. (AXSM) Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM ) securities...

AXSM : 31.65 (+0.44%)
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Investors to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Axsome Therapeutics, Inc. (“Axsome” or the “Company) (NASDAQ: AXSM)...

AXSM : 31.65 (+0.44%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Axsome Therapeutics, Inc. (AXSM) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Axsome Therapeutics, Inc. (“Axsome” or...

AXSM : 31.65 (+0.44%)
2 Under-the-Radar Biotech Stocks to Buy in 2022

Don't overlook these two promising companies.

INCY : 74.88 (+0.73%)
AXSM : 31.65 (+0.44%)
Shareholder Alert: Did You Purchase Shares of Axsome Therapeutics, Inc. (AXSM)? Robbins LLP Alerts Investors of Class Action Against Axsome Therapeutics, Inc.

The Class : Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Axsome Therapeutics,...

AXSM : 31.65 (+0.44%)
AXSOME ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Axsome Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Axsome Therapeutics, Inc. (“Axsome” or the “Company”)...

AXSM : 31.65 (+0.44%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Axsome Therapeutics, Inc. (AXSM) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM ) investors concerning the Company’s possible violations...

AXSM : 31.65 (+0.44%)
The Law Offices of Frank R. Cruz Announces Investigation of Axsome Therapeutics, Inc. (AXSM) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM ) on behalf of investors concerning the Company’s possible...

AXSM : 31.65 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 36.67
2nd Resistance Point 34.96
1st Resistance Point 33.31
Last Price 31.65
1st Support Level 29.95
2nd Support Level 28.24
3rd Support Level 26.59

See More

52-Week High 74.10
Fibonacci 61.8% 53.20
Fibonacci 50% 46.74
Fibonacci 38.2% 40.28
Last Price 31.65
52-Week Low 19.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar